Insights & knowledge sharing
Research, perspectives and practical frameworks on biotech and life sciences, portfolio decisions, transformation and value realization. I share what I am learning from the market and from years of working with complex investment and operating environments.
This is a growing library for founders, investors and leaders who want to connect strategic ambition with execution, organizational readiness and measurable progress.
Featured report
MARKET OUTLOOK / 2026
From scientific strength to scale-up.
IRENA PRÁŠILOVÁ
PRASILOVA ADVISORY
European market outlook · 2026
Europe has exceptional scientific depth and a growing policy focus on life sciences. Yet financing continuity, specialized capabilities and scale-up remain structural challenges. This report explores what those conditions may mean for biotech companies, investors and the operating capabilities needed to turn innovation and capital into repeatable progress.
Inside the report
• The European funding landscape and the limits of comparing different funding datasets.
• Why financing continuity and commercialization remain important scale-up challenges.
• Management questions around portfolio choices, governance, milestone tracking and resource allocation.
• Where operating-model and value-realization capabilities may support growing companies.
• A practical set of hypotheses to validate with founders, investors and portfolio operators.
Research note: this is directional market intelligence, not a paid market-sizing study or a verified database of buyers. It distinguishes published evidence from commercial hypotheses and does not position the author as a scientific, clinical or regulatory advisor.
Keep the conversation going
I welcome conversations with biotech founders, investors and life-sciences leaders who are exploring how to strengthen portfolio decisions, execution and value realization.